Eculizumab (Anti-Complement C5)
A2538
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameEculizumab (Anti-Complement C5) [219685-50-4]
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionEculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research. MW: 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203